BAMLANIVIMAB: New drug granted Emergency use Authorization

The investigational neutralizing IgG1 monoclonal antibody bamlanivimab has been granted an FDA Emergency Use Authorization (EUA) for treatment of recently diagnosed mild to moderate COVID-19 in patients who are ≥12 years old, weigh at least 40 kg, and are at high risk for progressing to severe disease and/or hospitalization. Bamlanivimab was shown in clinical trials…

LASI survey : 75 million elderly Indians suffer from multiple chronic diseases

The Longitudinal Aging Study in India (LASI) is a groundbreaking nationally-representative, longitudinal survey to examine aging and retirement among India’s 45+ population. It is a joint undertaking of the Harvard T.H. Chan School of Public Health, the International Institute for Population Sciences (IIPS) in Mumbai, India, and the University of Southern California. The study was…

Healthy Ageing: Why And How?

Healthy Ageing: Why and How? Geriatric care management is the process of planning and coordinating care of the elderly with physical and/or mental impairments to meet their long term care needs, improve their quality of life, and maintain their independence for as long as possible. According to the Census of India, the number of senior…